|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 318.00 EUR | -0.31% |
|
-2.30% | +0.47% |
| Apr. 16 | VIRBAC : Decent Q1; Clarity on US tariff exposure was a key takeaway |  |
| Apr. 16 | VIRBAC : Stifel still buying after Q1 results | CF |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VIRBAC | Veterinary Drugs | -0.31% | -2.30% | +0.47% | -6.33% | +77.26% | 3.08B |  |  |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- VIRP Stock
- Charts Virbac
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
